Skip to main content
. 2011 May-Jun;45(3):197–207. doi: 10.4103/0019-5413.80037

Table 1.

Various studies about incidence of deep vein thrombosis in Indian patients after major orthopedic trauma

Studies Study design Orthopedic trauma Diagnostic modalities Prophylaxis Incidence (%) Remarks
Sharma et al.,11 2002 Prospective 112 hip fractures Color Doppler Nil 19.6 (22/112) High incidence; advised thromboprophylaxis
Agarwala et al.,14 2003 Prospective 18 proximal femoral fractures Venography + LMWH (Dalteparin) 45.4 (5/11) in prophylaxis group; 71.4 (5/7) in non-prophylaxis group High incidence; advised thromboprophylaxis
Bhan et al.,24 2004 Prospective 15 lower-limb fractures + 10 spinal injuries Doppler ultrasound Mechanical prophylaxis (lymphavision) 0 (0/25) Advised mechanical prophylaxis
Agarwala et al.,15 2005 Prospective 12 patients with femoral neck fracture Color Doppler LMWH (Dalteparin) 0 (0/12) Advised prophylaxis
Maini et al.,17 2006 Retrospective Femoral neck fractures (271 patients) NA Initial 5 years: no prophylaxis; next 5 years: prophylaxis 9.9 (20 in non-prophylaxis group and 5 in prophylaxis-receiving group). No exact data about the number of patients in each group Significant reduction with prophylaxis
Bagaria et al.,26 2006 Prospective 102 proximal femur fractures Duplex ultrasonography Nil 6.8 (7/102) Low incidence; advised thromboprophylaxis in high-risk group
Rajgopalan,27 2007 Prospective 77 femur fractures Color Doppler ultrasound LMWH (Dalteparin) 6.49 (5/77) Advised prophylaxis
Mavalankar et al.,21 2007 Prospective 55 patients with lower-limb fractures Duplex ultrasonography Nil 10.91 (6/55) Advised prophylaxis in high-risk patients
Saraf et al.,25 2007 Prospective Acute spinal cord injury (70 patients) 42, color Doppler; 28, venography Nil 10 (7/70) Low incidence; however, advised routine screening. Clinical suspicion is inadequate
Agarwal et al.,23 2009 Prospective Acute spinal cord injury (297 patients) Color Doppler 166 with prophylaxis; 131, no prophylaxis 1.81 (3/166) in prophylaxis group; 3.05 (4/131) in non-prophylaxis group Low incidence, no significant effect of prophylactic heparin therapy